Sleeping better
Follow Gotrade News for timely coverage on US stocks, ETFs, and macro moves that shape market direction
Understanding GLP-1 Medications: GLP-1 receptor agonists work by mimicking a naturally occurring hormone, incretin, which stimulates insulin secretion and reduces appetite
GLP-1 medications trigger the bodys GLP-1 receptor, which increases insulin production, decreases glucagon release (another hormone that elevates blood sugar), slows gastric emptying (the pace at which food leaves the stomach), and intensifies sensations of fullness
The semaglutide component follows the same dose escalation schedule as standard compounded semaglutide: Weeks 1-4: 0.25 mg semaglutide (0.1 mL) Weeks 5-8: 0.5 mg semaglutide (0.2 mL) Weeks 9-12: 1.0 mg semaglutide (0.4 mL) Weeks 13-16: 1.7 mg semaglutide (0.68 mL) Week 17+: 2.4 mg semaglutide (0.96 mL) The niacinamide dose scales proportionally with the injection volume
Our reputation for delivering high-purity peptides suitable for research is backed by over a decade of experience